All data are based on the daily closing price as of November 12, 2025
o

Olympus

7733.TSE
13.40 USD
-0.14
-1.03%

Overview

Last close
13.40 usd
Market cap
14.85B usd
52 week high
19.68 usd
52 week low
11.24 usd
Target price
12.66 usd

Valuation

P/E
24.9363
Forward P/E
23.6407
Price/Sales
2.46
Price/Book Value
3.1248
Enterprise Value
15.24B usd
EV/Revenue
2.413
EV/EBITDA
11.1784

Key financials

Revenue TTM
6.32B usd
Gross Profit TTM
4.25B usd
EBITDA TTM
1.38B usd
Earnings per Share
0.56 usd
Dividend
0.13 usd
Total assets
9.37B usd
Net debt
585.95M usd

About

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
  • Symbol
    7733.TSE
  • Exchange
    TSE
  • Isin
    JP3201200007
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Stephen Kneebone
  • Headquarter
    Hachioji
  • Web site
    https://www.olympus.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top